NeuroPace (NPCE) Operating Expenses (2020 - 2026)

NeuroPace's Operating Expenses history runs 7 years deep, the most recent figure standing at $23.6 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 5.01% year-over-year to $23.6 million; the TTM figure through Mar 2026 stood at $94.7 million (up 14.97% YoY), while the FY2025 annual figure was $93.6 million, up 15.85% from the prior year.
• Operating Expenses was $23.6 million for Q1 2026 at NeuroPace, up from $22.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $25.0 million in Q2 2025 to a low of $18.0 million in Q1 2022.
• Historically, Operating Expenses has averaged $20.4 million across 5 years, with a median of $19.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Expenses surged 45.72% in 2022, then declined 0.35% in 2023.
• A 5-year view of Operating Expenses shows it stood at $18.7 million in 2022, then fell by 0.35% to $18.6 million in 2023, then rose by 6.69% to $19.8 million in 2024, then rose by 12.62% to $22.3 million in 2025, then climbed by 5.69% to $23.6 million in 2026.
• The last three Operating Expenses figures came in at $23.6 million (Q1 2026), $22.3 million (Q4 2025), and $23.8 million (Q3 2025), per Business Quant data.